EXACT Sciences Co. (EXAS) Earns "Neutral" Rating from Mizuho
's stock had its "neutral" rating reissued by research analysts at Mizuho in a research report issued on Wednesday. They currently have a $6.50 target price on the stock.
from Biotech News
's stock had its "neutral" rating reissued by research analysts at Mizuho in a research report issued on Wednesday. They currently have a $6.50 target price on the stock.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments